ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS INTERVENTIONS (ATN) SCIENTIFIC LEADERSHIP CENTER - ADOLESCENTS AND YOUNG ADULTS (AYA) UNDER THE AGE OF 25 IN THE UNITED STATES (US) ARE THE LEAST LIKELY OF ALL AGE GROUPS TO: 1) KNOW THEIR HIV STATUS, 2) INITIATE PREP IF HIV-NEGATIVE EVEN WHEN INDICATED, 3) TAKE MEDICATION AS PRESCRIBED, ATTEND MEDICAL APPOINTMENTS, AND BE VIRALLY SUPPRESSED IF LIVING WITH HIV. PERSISTENT RATES OF NEW INFECTIONS AMONG US YOUTH INDICATE THAT EVIDENCE-BASED AND INTEGRATED APPROACHES TO INCREASE THE UPTAKE AND USE OF EFFECTIVE BIOMEDICAL PREVENTION AND TREATMENT PRODUCTS ARE REQUIRED. ADOLESCENCE AND YOUNG ADULTHOOD ARE CHALLENGING DEVELOPMENTAL PERIODS, WITH SIGNIFICANT PHYSICAL, NEUROCOGNITIVE, EMOTIONAL, AND SOCIAL CHANGES. WHILE MULTIPLE VULNERABILITIES AND COMPLEX COMMUNITY FACTORS DRIVE THE HIV EPIDEMIC AMONG YOUTH, THESE DEVELOPMENTAL PERIODS ARE ALSO CHARACTERIZED BY OPPORTUNITIES FOR GROWTH, ACHIEVEMENT, AND RESILIENCE. HIV RESEARCH NETWORKS MUST BE

Summary

ADOLESCENT MEDICINE TRIALS NETWORK FOR HIV/AIDS INTERVENTIONS (ATN) SCIENTIFIC LEADERSHIP CENTER - ADOLESCENTS AND YOUNG ADULTS (AYA) UNDER THE AGE OF 25 IN THE UNITED STATES (US) ARE THE LEAST LIKELY OF ALL AGE GROUPS TO: 1) KNOW THEIR HIV STATUS, 2) INITIATE PREP IF HIV-NEGATIVE EVEN WHEN INDICATED, 3) TAKE MEDICATION AS PRESCRIBED, ATTEND MEDICAL APPOINTMENTS, AND BE VIRALLY SUPPRESSED IF LIVING WITH HIV. PERSISTENT RATES OF NEW INFECTIONS AMONG US YOUTH INDICATE THAT EVIDENCE-BASED AND INTEGRATED APPROACHES TO INCREASE THE UPTAKE AND USE OF EFFECTIVE BIOMEDICAL PREVENTION AND TREATMENT PRODUCTS ARE REQUIRED. ADOLESCENCE AND YOUNG ADULTHOOD ARE CHALLENGING DEVELOPMENTAL PERIODS, WITH SIGNIFICANT PHYSICAL, NEUROCOGNITIVE, EMOTIONAL, AND SOCIAL CHANGES. WHILE MULTIPLE VULNERABILITIES AND COMPLEX COMMUNITY FACTORS DRIVE THE HIV EPIDEMIC AMONG YOUTH, THESE DEVELOPMENTAL PERIODS ARE ALSO CHARACTERIZED BY OPPORTUNITIES FOR GROWTH, ACHIEVEMENT, AND RESILIENCE. HIV RESEARCH NETWORKS MUST BE